BuzzSparks.org

Bay City Capital


Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed six venture funds representing $1.5 billion in capital invested in over 70...

Founded in 1997
Homepage:

94111 750 Battery Street Suite 400

San Francisco
USA CA

Phone: 415.676.3830

Updated on Apr 13, 2013
Bay City Capital at CrunchBase
Kirby Bartlett Chief Administrative Officer
Manuel López-Figuero Vice President
Judy Koh Chief Financial Officer
H. Daniel Perez Venture Partner
Ross Bersot Investment Partner
Fred craves Managing Director
William Gerber Investment Partner
Carl Goldfischer Partner
Dayton Misfeldt Partner
Brian Cunningham Venture Partner
Tadaharu Wakabayashi Venture Partner
Marge Josephson Vice President, Human Resources and Operational Services
Susan Vuong Controller
Hoyoung Huh Advisor
Thomas Pritzker Advisor
Mervyn Turner Advisor
Jeff Friedman Scientific Advisory Board
Alan Glassberg Scientific Advisory Board
Lester Kaplan Scientific Advisory Board
Richard Lerner Scientific Advisory Board
David Beier Managing Director
Nathan Pliam Venture Partner
LIONEL CARNOT Partner
Jeanne Cunicelli partner
Doug Given Partner
Rob Hopfner Investment Partner
Israel Charo Venture Partner
Vic Schmitt Venture Partner
Matt Kronmiller Analyst
Stacey Leaño Senior Director
Nevan Elam Advisor
David Milligan Advisor
Nicholas J. Pritzker Advisor
E Rolland Dickson Scientific Advisory Board
Fred Gage Scientific Advisory Board
Paul Greengard Scientific Advisory Board
Ronald Krauss Scientific Advisory Board
Richard Myers Scientific Advisory Board
Past
Konstantinos Alataris Vice President - Healthcare Venture Investments
Andy Schwab Principal
Nina Kjellson Investment Manager
Bill Burkoth Analyst
Chris Griffith Investment Management

October, 2013

Bay City Capital invested $10M in PharmAkea Therapeutics as a Series A round

Bay City Capital invested $41.9M in Merus as a Series B round

Bay City Capital invested $10M in Cydan as unattributed round

July, 2013

Bay City Capital invested $45.5M in TRIA Beauty as private_equity round

June, 2013

Bay City Capital invested $10M in Aviir as a Series B round

Bay City Capital invested $35M in Dermira as a Series B round

March, 2013

Bay City Capital invested $35M in Nabsys as a Series D round

Bay City Capital invested $48M in Nevro as a Series C round

February, 2013

Bay City Capital invested $10M in Aviir as a Series B round

April, 2012

Bay City Capital invested $5M in SynGen as a Series A round

February, 2012

Bay City Capital invested $12.5M in Altheos as a Series A round

December, 2011

Bay City Capital invested $10M in Aviir as a Series B round

Bay City Capital invested $3.8M in Aviir as unattributed round

October, 2011

Bay City Capital invested $42M in Dermira as a Series A round

July, 2011

Bay City Capital invested $58M in Nevro as unattributed round

February, 2011

Bay City Capital invested $20M in Conatus Pharmaceuticals as a Series B round

January, 2011

Bay City Capital invested $45M in NextWave Pharmaceuticals as a Series C round

October, 2010

Bay City Capital invested $46M in IDEV Technologies as a Series D round

April, 2010

Bay City Capital invested $20M in Altheos as a Series A round

January, 2010

Bay City Capital invested $29.3M in Merus as a Series B round

Bay City Capital invested $4.2M in Aviir as unattributed round

November, 2009

Bay City Capital invested $8.6M in Metabolex as unattributed round

Bay City Capital invested $50M in Calypso Medical as a Series E round

October, 2009

Bay City Capital invested $1M in Aviir as unattributed round

Bay City Capital invested $32M in Epizyme as a Series B round

August, 2009

Bay City Capital invested $1M in Aviir as unattributed round

April, 2009

Bay City Capital invested $43.5M in Sunesis Pharmaceuticals as unattributed round

March, 2009

Bay City Capital invested $10M in VIA Pharmaceuticals as debt_round round

December, 2008

Bay City Capital invested $7.8M in Aviir as unattributed round

March, 2008

Bay City Capital invested $30M in BrainCells as a Series B round

January, 2008

Bay City Capital invested $25M in Aragon Surgical as a Series B round

September, 2007

Bay City Capital invested $11.4M in Aviir as unattributed round

August, 2007

Bay City Capital invested $26M in Presidio Pharmaceuticals as a Series B round

May, 2007

Bay City Capital invested $2M in Vivaldi Biosciences as a Series A round

April, 2007

Bay City Capital invested $32M in Metabolex as a Series D round

March, 2007

Bay City Capital invested $50M in MAP Pharmaceuticals as a Series D round

Bay City Capital invested $55M in Phenomix as a Series C round

November, 2005

Bay City Capital invested $26.6M in PTC Therapeutics as unattributed round

August, 2002

Bay City Capital invested unknown amount in Epocrates as a Series C round

August, 2000

Bay City Capital invested $35M in Epocrates as a Series B round

1997

Bay City Capital was founded in 1997